Jack Cuzick

Jack Cuzick is the John Snow Professor of Epidemiology at Queen Mary University of London, heading the Cancer Prevention unit within the Wolfson Institute of Population Health. He previously directed the Wolfson Institute of Preventive Medicine and the Centre for Cancer Prevention. With a PhD in Mathematics, he has held roles at Oxford University and Columbia University. His research focuses on cancer epidemiology, clinical trials, and prevention/screening strategies, particularly breast, cervical, and prostate cancers. He is a leading authority on HPV-based cervical screening, chemoprevention, and biomarker development.

Key achievements include pioneering work on tamoxifen’s role in breast cancer prevention, developing molecular markers for cancer prognosis, and leading major trials like IBIS and ATAC. Cuzick has authored over 500 peer-reviewed papers in top journals and earned prestigious awards, including the CBE and CRUK Lifetime Achievement Prize.

Education:

• PhD in Mathematics

Research Interests:

• Chemoprevention of breast cancer
• HPV-based cervical screening
• Colorectal cancer screening via flexible sigmoidoscopy
• Prostate cancer biomarkers and risk assessment
• Statistical methodologies for clinical trials
• Personalized risk-based cancer screening strategies

Recent Research Trends: Focus on polygenic risk scores, epigenetic biomarkers (e.g., DNA methylation), and computational pathology tools for predicting treatment response. Recent studies explore aspirin’s role in cancer prevention and the impact of hormonal factors on anastrozole efficacy.

Awards:

• Fellowships: Royal Society, Academy of Medical Sciences, Royal Statistical Society
• 2017 CBE (services to cancer prevention)
• CRUK Lifetime Achievement Prize (2017)
• AACR Cancer Prevention Prize (2012)

Grants/Advising: Leads major initiatives like the IBIS-II Prevention Trial and the ATAC Trial. Collaborates on global projects such as the International Breast Cancer Intervention Study (IBIS) and the ARTISTIC cohort for cervical cancer biomarkers. No formal student advisee list is provided in the text.

Labs/Teams: Directs the Cancer Prevention unit and collaborates with the Centre for Prevention, Detection and Diagnosis at Queen Mary. Engages with international networks like the Trans-Atlantic Prostate Group.